Frequently Asked Questions
The market is segmented based on , By Type (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma, Others), Drug Class (Beta Blockers, Prostaglandins, Alpha Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Combination Drugs, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Open Angle Glaucoma Market size was valued at USD 5.20 USD Million in 2022.
The Global Open Angle Glaucoma Market is projected to grow at a CAGR of 4% during the forecast period of 2023 to 2030.
The major players operating in the market include Aerie Pharmaceuticals, Abbvie, Bausch Health Companies, Merck & Co, Pfizer, Fera Pharmaceuticals, Teva Pharmaceutical Industries, EyePoint Pharmaceuticals, Amorphex Therapeutics Holdings, Kubota Vision, Alcon, Astellas Pharma, Bayer AG, Novartis AG, Carl Zeiss Meditec AG, Nidek Co Ltd, Accutome, AqueSys, Iridex Corporation.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
